Vault-13

DEERFIELD MANAGEMENT COMPANY, L.P.

New York, NY · CIK 1009258 · 13F filing filed 2025-08-14

SEC-registered investment adviser since 2012 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 86
Parsippany, NJUnited States United States3

US visa salary filings

Job titleFilingsMedianRange
AnalystNew York, NY 2 $140,000
Data EngineerNew York, NY 1 $210,000
Senior Director, Business IntelligenceNew York, NY 1 $195,000
Director, Business IntelligenceNew York, NY 1 $180,000
Market Research AssociateNew York, NY 1 $80,000

Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Deerfield Management Company, L.P..

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$5.5bn reported value +9.2% vs Q1 2025
124positions
54.2%in top 10
45 new 28 added 13 reduced 43 sold out vs Q1 2025

This report includes the holdings of 1 other manager that shares the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 NUVALENT INC COM COM 17,991,024 $1.4bn24.91% 24.91% UnchangedShares held: Q3 2024 20.0m, Q4 2024 18.0m, Q1 2025 18.0m, Q2 2025 18.0m
2 OSCAR HEALTH INC CL A OSCR OSCR 11,649,591 $249.8m4.53% 4.53% ReducedShares held: Q3 2024 7.9m, Q4 2024 11.8m, Q1 2025 11.8m, Q2 2025 11.6m -191.2k -191,227 -1.6%
3 VIATRIS INC COM VTRS VTRS 24,023,907 $214.5m3.89% 3.89% AddedShares held: Q3 2024 24.0m, Q4 2024 24.0m, Q1 2025 24.0m, Q2 2025 24.0m +32.3k +32,313 0.1%
4 MERUS N V COM MRUS MRUS 3,384,628 $178.0m3.23% 3.23% AddedShares held: Q3 2024 3.4m, Q4 2024 3.0m, Q1 2025 3.2m, Q2 2025 3.4m +210.7k +210,700 6.6%
5 CENTENE CORP DEL COM CNC CNC 3,185,370 $172.9m3.14% 3.14% AddedShares held: Q3 2024 2.7m, Q4 2024 2.7m, Q1 2025 2.7m, Q2 2025 3.2m +513.4k +513,449 19.2%
6 INTEGRA LIFESCIENCES HLDGS C NOTE 0.500% 8/1 · principal IART 0.5 08.15.25 · principal IART 0.5 08.15.25 174,364,000 $172.9m3.14% 3.14% UnchangedPrincipal held: Q3 2024 174.4m, Q4 2024 174.4m, Q1 2025 174.4m, Q2 2025 174.4m
7 ARS PHARMACEUTICALS INC COM SPRY SPRY 9,724,508 $169.7m3.08% 3.08% ReducedShares held: Q3 2024 11.1m, Q4 2024 10.5m, Q1 2025 10.5m, Q2 2025 9.7m -790.1k -790,149 -7.5%
8 INDIVIOR PLC ORD INDV INDV 10,567,160 $155.8m2.83% 2.83% UnchangedShares held: Q3 2024 5.1m, Q4 2024 8.9m, Q1 2025 10.6m, Q2 2025 10.6m
9 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 540,626 $155.3m2.82% 2.82% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 275.2k, Q2 2025 540.6k +265.4k +265,400 96.4%
10 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 1,167,802 $146.8m2.66% 2.66% ReducedShares held: Q3 2024 1.3m, Q4 2024 862.0k, Q1 2025 1.5m, Q2 2025 1.2m -321.2k -321,198 -21.6%
11 ALNYLAM PHARMACEUTICALS INC NOTE 1.000% 9/1 · principal ALNY 1 09.15.27 · principal ALNY 1 09.15.27 110,000,000 $143.2m2.60% 2.60% UnchangedPrincipal held: Q3 2024 100.0m, Q4 2024 110.0m, Q1 2025 110.0m, Q2 2025 110.0m
12 REVOLUTION MEDICINES INC COM RVMD RVMD 3,384,072 $124.5m2.26% 2.26% AddedShares held: Q3 2024 2.9m, Q4 2024 3.3m, Q1 2025 3.3m, Q2 2025 3.4m +66.7k +66,740 2.0%
13 MIRUM PHARMACEUTICALS INC NOTE 4.000% 5/0 · principal MIRM 4 05.01.29 · principal MIRM 4 05.01.29 70,000,000 $124.2m2.25% 2.25% UnchangedPrincipal held: Q3 2024 70.0m, Q4 2024 70.0m, Q1 2025 70.0m, Q2 2025 70.0m
14 BROOKDALE SR LIVING INC COM BKD BKD 15,362,264 $106.9m1.94% 1.94% ReducedShares held: Q3 2024 15.6m, Q4 2024 15.6m, Q1 2025 15.6m, Q2 2025 15.4m -250.0k -250,000 -1.6%
15 LEGEND BIOTECH CORP SPONSORED ADS LEGN LEGN 2,962,338 $105.1m1.91% 1.91% AddedShares held: Q3 2024 0, Q4 2024 1.6m, Q1 2025 1.7m, Q2 2025 3.0m +1.2m +1,218,783 69.9%
16 PFIZER INC COM PFE PFE 4,306,264 $104.4m1.89% 1.89% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 3.3m, Q2 2025 4.3m +959.0k +958,968 28.6%
17 ADAPTHEALTH CORP COMMON STOCK AHCO AHCO 9,904,895 $93.4m1.70% 1.70% AddedShares held: Q3 2024 9.7m, Q4 2024 9.7m, Q1 2025 9.7m, Q2 2025 9.9m +193.5k +193,485 2.0%
18 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 5,115,953 $92.6m1.68% 1.68% AddedShares held: Q3 2024 901.8k, Q4 2024 4.3m, Q1 2025 4.1m, Q2 2025 5.1m +1.0m +1,011,996 24.7%
19 IDEAYA BIOSCIENCES INC COM IDYA IDYA 3,915,311 $82.3m1.49% 1.49% AddedShares held: Q3 2024 2.6m, Q4 2024 2.7m, Q1 2025 3.3m, Q2 2025 3.9m +647.8k +647,760 19.8%
20 VERA THERAPEUTICS INC CL A VERA VERA 3,348,117 $78.9m1.43% 1.43% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 1.1m, Q2 2025 3.3m +2.3m +2,298,117 218.9%
21 INSMED INC COM PAR $.01 INSM INSM 700,700 $70.5m1.28% 1.28% AddedShares held: Q3 2024 52.9k, Q4 2024 0, Q1 2025 458.0k, Q2 2025 700.7k +242.7k +242,700 53.0%
22 MERCK & CO INC COM MRK MRK 857,724 $67.9m1.23% 1.23% NewShares held: Q3 2024 8.5k, Q4 2024 0, Q1 2025 0, Q2 2025 857.7k
23 CATALYST PHARMACEUTICALS INC COM CPRX CPRX 2,879,476 $62.5m1.13% 1.13% ReducedShares held: Q3 2024 6.2m, Q4 2024 3.1m, Q1 2025 3.4m, Q2 2025 2.9m -542.7k -542,673 -15.9%
24 LARIMAR THERAPEUTICS INC COM LRMR LRMR 21,231,974 $61.4m1.11% 1.11% UnchangedShares held: Q3 2024 21.2m, Q4 2024 21.2m, Q1 2025 21.2m, Q2 2025 21.2m
25 BAXTER INTL INC COM BAX BAX 1,923,100 $58.2m1.06% 1.06% UnchangedShares held: Q3 2024 1.9m, Q4 2024 1.9m, Q1 2025 1.9m, Q2 2025 1.9m
26 BIO RAD LABS INC CL A BIO BIO 226,070 $54.6m0.99% 0.99% UnchangedShares held: Q3 2024 151.6k, Q4 2024 151.6k, Q1 2025 226.1k, Q2 2025 226.1k
27 DISC MEDICINE INC COM IRON IRON 919,403 $48.7m0.88% 0.88% AddedShares held: Q3 2024 1.0m, Q4 2024 600.5k, Q1 2025 782.3k, Q2 2025 919.4k +137.1k +137,070 17.5%
28 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 145,000 $47.3m0.86% 0.86% UnchangedShares held: Q3 2024 145.0k, Q4 2024 145.2k, Q1 2025 145.0k, Q2 2025 145.0k
29 ENHABIT INC COM EHAB EHAB 4,779,864 $46.1m0.84% 0.84% ReducedShares held: Q3 2024 5.0m, Q4 2024 5.0m, Q1 2025 5.0m, Q2 2025 4.8m -217.9k -217,882 -4.4%
30 CERTARA INC COM CERT CERT 3,926,099 $45.9m0.83% 0.83% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 2.0m, Q2 2025 3.9m +1.9m +1,903,483 94.1%
31 ENVISTA HOLDINGS CORPORATION COM NVST NVST 2,215,845 $43.3m0.79% 0.79% AddedShares held: Q3 2024 20.2k, Q4 2024 1.0m, Q1 2025 2.0m, Q2 2025 2.2m +190.9k +190,902 9.4%
32 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 4,692,000 $42.0m0.76% 0.76% ReducedShares held: Q3 2024 8.1m, Q4 2024 8.1m, Q1 2025 5.2m, Q2 2025 4.7m -497.7k -497,665 -9.6%
33 TANDEM DIABETES CARE INC NOTE 1.500% 3/1 · principal TNDM 1.5 03.15.29 2024 · principal TNDM 1.5 03.15.29 2024 40,000,000 $38.5m0.70% 0.70% NewPrincipal held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 40.0m
34 CONMED CORP COM CNMD CNMD 700,271 $36.5m0.66% 0.66% AddedShares held: Q3 2024 614.9k, Q4 2024 612.0k, Q1 2025 611.0k, Q2 2025 700.3k +89.3k +89,271 14.6%
35 PHARVARIS N V COM PHVS PHVS 2,017,464 $35.5m0.64% 0.64% UnchangedShares held: Q3 2024 2.0m, Q4 2024 2.0m, Q1 2025 2.0m, Q2 2025 2.0m
36 LANTHEUS HLDGS INC NOTE 2.625%12/1 · principal LNTH 2.625 12.15.27 · principal LNTH 2.625 12.15.27 25,255,000 $32.1m0.58% 0.58% UnchangedPrincipal held: Q3 2024 25.3m, Q4 2024 25.3m, Q1 2025 25.3m, Q2 2025 25.3m
37 CULLINAN THERAPEUTICS INC COM CGEM CGEM 3,855,552 $29.0m0.53% 0.53% ReducedShares held: Q3 2024 3.3m, Q4 2024 3.4m, Q1 2025 3.9m, Q2 2025 3.9m -5.3k -5,287 -0.1%
38 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 686,931 $28.9m0.52% 0.52% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 619.9k, Q2 2025 686.9k +67.0k +67,000 10.8%
39 PHREESIA INC COM PHR PHR 1,014,577 $28.9m0.52% 0.52% AddedShares held: Q3 2024 544.4k, Q4 2024 1.3m, Q1 2025 1.0m, Q2 2025 1.0m +4.7k +4,733 0.5%
40 KYMERA THERAPEUTICS INC COM KYMR KYMR 653,000 $28.5m0.52% 0.52% AddedShares held: Q3 2024 0, Q4 2024 593.0k, Q1 2025 593.0k, Q2 2025 653.0k +60.0k +60,000 10.1%
41 MODERNA INC COM MRNA MRNA 1,000,000 $27.6m0.50% 0.50% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 1.0m
42 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 2,067,320 $27.1m0.49% 0.49% ReducedShares held: Q3 2024 1.8m, Q4 2024 2.1m, Q1 2025 2.1m, Q2 2025 2.1m -11.2k -11,189 -0.5%
43 EMBECTA CORP COMMON STOCK EMBC EMBC 2,749,712 $26.6m0.48% 0.48% AddedShares held: Q3 2024 2.7m, Q4 2024 3.3m, Q1 2025 2.7m, Q2 2025 2.7m +29.2k +29,177 1.1%
44 IMMUNOCORE HLDGS PLC NOTE 2.500% 2/0 · principal IMCR 2.5 02.01.30 · principal IMCR 2.5 02.01.30 30,000,000 $25.8m0.47% 0.47% UnchangedPrincipal held: Q3 2024 0, Q4 2024 0, Q1 2025 30.0m, Q2 2025 30.0m
45 LIVANOVA PLC NOTE 2.500% 3/1 · principal LIVN 2.5 03.15.29 · principal LIVN 2.5 03.15.29 25,000,000 $25.4m0.46% 0.46% NewPrincipal held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 25.0m
46 DAY ONE BIOPHARMACEUTICALS I COM COM 3,723,131 $24.2m0.44% 0.44% AddedShares held: Q3 2024 2.6m, Q4 2024 2.6m, Q1 2025 3.0m, Q2 2025 3.7m +762.4k +762,391 25.8%
47 VENTAS INC COM VTR VTR 354,000 $22.4m0.41% 0.41% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 354.0k
48 LIQUIDIA CORPORATION COM NEW LQDA LQDA 1,616,778 $20.1m0.37% 0.37% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 1.6m, Q2 2025 1.6m
49 COGENT BIOSCIENCES INC COM COGT COGT 2,640,215 $19.0m0.34% 0.34% AddedShares held: Q3 2024 3.7m, Q4 2024 2.6m, Q1 2025 2.6m, Q2 2025 2.6m +6.4k +6,353 0.2%
50 MEREO BIOPHARMA GROUP PLC SPON ADS MREO MREO 6,710,429 $18.2m0.33% 0.33% UnchangedShares held: Q3 2024 6.7m, Q4 2024 6.7m, Q1 2025 6.7m, Q2 2025 6.7m
51 INSPIRE MED SYS INC COM INSP INSP 140,000 $18.2m0.33% 0.33% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 140.0k
52 SAVARA INC COM SVRA SVRA 7,964,000 $18.2m0.33% 0.33% UnchangedShares held: Q3 2024 6.5m, Q4 2024 8.0m, Q1 2025 8.0m, Q2 2025 8.0m
53 XERIS BIOPHARMA HOLDINGS INC NOTE 8.000% 7/1 · principal XERS 8 07.15.28 · principal XERS 8 07.15.28 10,500,000 $17.7m0.32% 0.32% UnchangedPrincipal held: Q3 2024 0, Q4 2024 0, Q1 2025 10.5m, Q2 2025 10.5m
54 BETA BIONICS INC COM BBNX BBNX 1,168,415 $17.0m0.31% 0.31% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 1.0m, Q2 2025 1.2m +152.4k +152,415 15.0%
55 XENON PHARMACEUTICALS INC COM XENE XENE 542,020 $17.0m0.31% 0.31% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 542.0k
56 VERACYTE INC COM VCYT VCYT 625,000 $16.9m0.31% 0.31% NewShares held: Q3 2024 12.0k, Q4 2024 0, Q1 2025 0, Q2 2025 625.0k
57 SIONNA THERAPEUTICS INC COM SION SION 970,590 $16.8m0.31% 0.31% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 747.0k, Q2 2025 970.6k +223.6k +223,590 29.9%
58 NEOGENOMICS INC COM NEW NEO NEO 2,148,000 $15.7m0.28% 0.28% NewShares held: Q3 2024 9.5k, Q4 2024 0, Q1 2025 0, Q2 2025 2.1m
59 FOGHORN THERAPEUTICS INC COM FHTX FHTX 3,255,514 $15.3m0.28% 0.28% UnchangedShares held: Q3 2024 3.0m, Q4 2024 3.3m, Q1 2025 3.3m, Q2 2025 3.3m
60 ZENAS BIOPHARMA INC COM ZBIO ZBIO 1,562,942 $15.1m0.27% 0.27% UnchangedShares held: Q3 2024 1.6m, Q4 2024 1.6m, Q1 2025 1.6m, Q2 2025 1.6m
61 NOVOCURE LTD ORD SHS NVCR NVCR 825,119 $14.7m0.27% 0.27% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 650.1k, Q2 2025 825.1k +175.0k +175,000 26.9%
62 TAYSHA GENE THERAPIES INC COM SHS TSHA TSHA 5,386,000 $12.4m0.23% 0.23% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 5.4m
63 RXSIGHT INC COM RXST RXST 888,950 $11.6m0.21% 0.21% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 392.3k, Q2 2025 889.0k +496.6k +496,618 126.6%
64 DELCATH SYS INC COM NEW DCTH DCTH 812,561 $11.1m0.20% 0.20% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 813.1k, Q2 2025 812.6k -545 -545 -0.1%
65 OMADA HEALTH INC COM OMDA OMDA 553,107 $10.1m0.18% 0.18% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 553.1k
66 INTEGRA LIFESCIENCES HLDGS C COM NEW IART IART 794,865 $9.8m0.18% 0.18% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 794.9k, Q2 2025 794.9k
67 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 613,665 $9.2m0.17% 0.17% AddedShares held: Q3 2024 0, Q4 2024 450.0k, Q1 2025 450.0k, Q2 2025 613.7k +163.7k +163,665 36.4%
68 DOCGO INC COM DCGO DCGO 4,941,565 $7.8m0.14% 0.14% ReducedShares held: Q3 2024 9.1m, Q4 2024 7.2m, Q1 2025 5.1m, Q2 2025 4.9m -109.9k -109,935 -2.2%
69 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 373,407 $7.7m0.14% 0.14% UnchangedShares held: Q3 2024 844.4k, Q4 2024 373.4k, Q1 2025 373.4k, Q2 2025 373.4k
70 VAXCYTE INC COM PCVX PCVX 225,000 $7.3m0.13% 0.13% UnchangedShares held: Q3 2024 225.0k, Q4 2024 225.0k, Q1 2025 225.0k, Q2 2025 225.0k
71 THE ONCOLOGY INSTITUTE INC COM STLN STLN 3,360,052 $6.9m0.13% 0.13% UnchangedShares held: Q3 2024 3.4m, Q4 2024 3.4m, Q1 2025 3.4m, Q2 2025 3.4m
72 SIMULATIONS PLUS INC COM COM 354,089 $6.2m0.11% 0.11% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 354.1k, Q2 2025 354.1k
73 NEUROPACE INC COM NPCE NPCE 500,000 $5.6m0.10% 0.10% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 500.0k, Q2 2025 500.0k
74 JADE BIOSCIENCES INC COM NEW JBIO JBIO 531,163 $5.3m0.10% 0.10% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 531.2k
75 PULMONX CORP COM LUNG LUNG 1,890,000 $4.9m0.09% 0.09% UnchangedShares held: Q3 2024 0, Q4 2024 1.5m, Q1 2025 1.9m, Q2 2025 1.9m
76 ALIGNMENT HEALTHCARE INC COM ALHC ALHC 342,558 $4.8m0.09% 0.09% ReducedShares held: Q3 2024 10.9m, Q4 2024 7.3m, Q1 2025 4.6m, Q2 2025 342.6k -4.2m -4,224,915 -92.5%
77 HILLEVAX INC COM COM 1,882,654 $3.7m0.07% 0.07% UnchangedShares held: Q3 2024 1.9m, Q4 2024 1.9m, Q1 2025 1.9m, Q2 2025 1.9m
78 CALCIMEDICA INC COM NEW COM NEW 1,300,000 $2.1m0.04% 0.04% UnchangedShares held: Q3 2024 1.0m, Q4 2024 1.3m, Q1 2025 1.3m, Q2 2025 1.3m
79 ALECTOR INC COM ALEC ALEC 1,055,192 $1.5m0.03% 0.03% UnchangedShares held: Q3 2024 1.1m, Q4 2024 1.1m, Q1 2025 1.1m, Q2 2025 1.1m
80 ANNEXON INC COM ANNX ANNX 583,913 $1.4m0.03% 0.03% UnchangedShares held: Q3 2024 583.9k, Q4 2024 583.9k, Q1 2025 583.9k, Q2 2025 583.9k
81 BIOMX INC COM NEW COM NEW 2,494,108 $1.1m0.02% 0.02% UnchangedShares held: Q3 2024 1.8m, Q4 2024 1.8m, Q1 2025 2.5m, Q2 2025 2.5m
82 TWIST BIOSCIENCE CORP COM TWST TWST 23,827 $876.6k0.02% 0.02% UnchangedShares held: Q3 2024 23.4k, Q4 2024 23.8k, Q1 2025 23.8k, Q2 2025 23.8k
83 NEWAMSTERDAM PHARMA COMPANY *W EXP 11/22/202 NAMSW NAMSW 92,787 $742.3k0.01% 0.01% UnchangedShares held: Q3 2024 92.8k, Q4 2024 92.8k, Q1 2025 92.8k, Q2 2025 92.8k
84 SOTERA HEALTH CO COM SHC SHC 45,242 $503.1k0.01% 0.01% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 45.2k
85 COOPER COS INC COM COO COO 6,328 $450.3k0.01% 0.01% NewShares held: Q3 2024 3.7k, Q4 2024 0, Q1 2025 0, Q2 2025 6.3k
86 THERMO FISHER SCIENTIFIC INC COM TMO TMO 916 $371.4k0.01% 0.01% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 916
87 UFP TECHNOLOGIES INC COM UFPT UFPT 1,517 $370.4k0.01% 0.01% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 1.5k
88 ALIGN TECHNOLOGY INC COM ALGN ALGN 1,945 $368.2k0.01% 0.01% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 1.9k
89 ATRICURE INC COM ATRC ATRC 11,138 $365.0k0.01% 0.01% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 11.1k
90 LEMAITRE VASCULAR INC COM LMAT LMAT 4,169 $346.2k0.01% 0.01% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 4.2k
91 ORTHOPEDIATRICS CORP COM KIDS KIDS 15,486 $332.6k0.01% 0.01% NewShares held: Q3 2024 17.9k, Q4 2024 0, Q1 2025 0, Q2 2025 15.5k
92 ENOVIS CORPORATION COM ENOV ENOV 10,267 $322.0k0.01% 0.01% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 10.3k
93 NATIONAL HEALTHCARE CORP COM NHC NHC 2,926 $313.1k0.01% 0.01% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 2.9k
94 DAVITA INC COM DVA DVA 2,101 $299.3k0.01% 0.01% NewShares held: Q3 2024 2.5k, Q4 2024 0, Q1 2025 0, Q2 2025 2.1k
95 BIOLIFE SOLUTIONS INC COM NEW BLFS BLFS 13,670 $294.5k0.01% 0.01% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 13.7k
96 UNIVERSAL HLTH SVCS INC CL B UHS UHS 1,597 $289.3k0.01% 0.01% NewShares held: Q3 2024 1.7k, Q4 2024 0, Q1 2025 0, Q2 2025 1.6k
97 AMEDISYS INC COM AMED AMED 2,744 $270.0k0.00% 0.00% NewShares held: Q3 2024 10.1k, Q4 2024 0, Q1 2025 0, Q2 2025 2.7k
98 HAEMONETICS CORP MASS COM HAE HAE 3,529 $263.3k0.00% 0.00% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 3.5k
99 IQVIA HLDGS INC COM IQV IQV 1,623 $255.8k0.00% 0.00% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 1.6k
100 MIMEDX GROUP INC COM MDXG MDXG 39,351 $240.4k0.00% 0.00% NewShares held: Q3 2024 92.5k, Q4 2024 0, Q1 2025 0, Q2 2025 39.4k

Sold out since Q1 2025

SecurityTickerShares held beforeValue then
ACCOLADE INC ACCD 0.5 04.01.26 ACCD 0.5 04.01.26 132,598,000 $130.6m132.6m shares
DYNAVAX TECHNOLOGIES CORP DVAX DVAX 5,191,493 $67.3m5.2m shares
CHIMERIX INC CMRX CMRX 3,771,342 $32.1m3.8m shares
INMODE LTD INMD INMD 1,578,708 $28.0m1.6m shares
LANTHEUS HLDGS INC LNTH LNTH 240,218 $23.4m240.2k shares
CG ONCOLOGY INC CGON CGON 850,695 $20.8m850.7k shares
BEAM THERAPEUTICS INC BEAM BEAM 877,809 $17.1m877.8k shares
CONCENTRA GROUP HOLDINGS PAR CON CON 650,000 $14.1m650.0k shares
METSERA INC 500,000 $13.6m500.0k shares
OPKO HEALTH INC OPK OPK 6,906,362 $11.5m6.9m shares
GH RESEARCH PLC GHRS GHRS 925,000 $10.2m925.0k shares
DYNE THERAPEUTICS INC DYN DYN 812,408 $8.5m812.4k shares
PERSPECTIVE THERAPEUTICS INC CATX CATX 2,829,413 $6.0m2.8m shares
NEUROGENE INC NGNE NGNE 446,880 $5.2m446.9k shares
ST JOE CO JOE JOE 4,473 $210.0k4.5k shares
DXC TECHNOLOGY CO DXC DXC 11,883 $202.6k11.9k shares
XPONENTIAL FITNESS INC XPOF XPOF 23,097 $192.4k23.1k shares
FARMLAND PARTNERS INC FPI FPI 16,863 $188.0k16.9k shares
HALLADOR ENERGY COMPANY HNRG HNRG 13,713 $168.4k13.7k shares
RING ENERGY INC REI REI 127,376 $146.5k127.4k shares
MFA FINL INC MFA MFA 10,935 $112.2k10.9k shares
PETCO HEALTH & WELLNESS CO I WOOF WOOF 35,446 $108.1k35.4k shares
BACKBLAZE INC BLZE BLZE 21,475 $103.7k21.5k shares
VIR BIOTECHNOLOGY INC VIR VIR 15,728 $101.9k15.7k shares
MEDIAALPHA INC MAX MAX 10,795 $99.7k10.8k shares

Trades reported as a company insider in Q2 2025

Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.

DateCompanyTickerTradeShares ValueTheir holding
2025-06-27 ARS PHARMACEUTICALS INC 10% owner · Through Deerfield Private Design Fund III, L.P. SPRY Sold 370,075 $6.8m370.1k shares -7%
2025-06-27 ARS PHARMACEUTICALS INC 10% owner · Through Deerfield Private Design Fund IV, L.P. SPRY Sold 370,074 $6.8m370.1k shares -7%